ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Wellspring Biosciences Announces IND Clearance to Start Trial of ARS-3248
May 22, 2019Wellspring Biosciences announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for ARS-3248, a small molecule KRAS G12C inhibitor. -
Wellspring Biosciences Announces IND Application Clearance to Initiate ARS-3248 Trial
May 17, 2019Wellspring Biosciences, a wholly owned subsidiary of Araxes Pharma, announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for ARS-3248 ...
Pharma Sources Insight January 2025
